BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 15942643)

  • 1. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
    Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW
    Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells and EpCAM expression in neuroendocrine tumors.
    Khan MS; Tsigani T; Rashid M; Rabouhans JS; Yu D; Luong TV; Caplin M; Meyer T
    Clin Cancer Res; 2011 Jan; 17(2):337-45. PubMed ID: 21224371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
    Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
    Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.
    Nagahara T; Shiraha H; Sawahara H; Uchida D; Takeuchi Y; Iwamuro M; Kataoka J; Horiguchi S; Kuwaki T; Onishi H; Nakamura S; Takaki A; Nouso K; Yamamoto K
    Oncol Rep; 2015 Sep; 34(3):1169-77. PubMed ID: 26165819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
    Patriarca C; Macchi RM; Marschner AK; Mellstedt H
    Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.
    de Wit S; van Dalum G; Lenferink AT; Tibbe AG; Hiltermann TJ; Groen HJ; van Rijn CJ; Terstappen LW
    Sci Rep; 2015 Jul; 5():12270. PubMed ID: 26184843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPCAM-A novel molecular target for the treatment of pediatric and adult germ cell tumors.
    Schönberger S; Okpanyi V; Calaminus G; Heikaus S; Leuschner I; Nicholson JC; Stoecklein NH; Schneider DT; Borkhardt A
    Genes Chromosomes Cancer; 2013 Jan; 52(1):24-32. PubMed ID: 22987628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
    Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
    Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
    Lustberg MB; Balasubramanian P; Miller B; Garcia-Villa A; Deighan C; Wu Y; Carothers S; Berger M; Ramaswamy B; Macrae ER; Wesolowski R; Layman RM; Mrozek E; Pan X; Summers TA; Shapiro CL; Chalmers JJ
    Breast Cancer Res; 2014 Mar; 16(2):R23. PubMed ID: 24602188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation.
    van der Gun BTF; Wasserkort R; Monami A; Jeltsch A; Raskó T; Ślaska-Kiss K; Cortese R; Rots MG; de Leij LFMH; Ruiters MHJ; Kiss A; Weinhold E; McLaughlin PMJ
    Int J Cancer; 2008 Jul; 123(2):484-489. PubMed ID: 18398839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
    Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
    Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
    J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).
    El-Sahwi K; Bellone S; Cocco E; Casagrande F; Bellone M; Abu-Khalaf M; Buza N; Tavassoli FA; Hui P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Mol Cancer Ther; 2010 Jan; 9(1):57-66. PubMed ID: 20053761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the enumeration and phenotyping of CTC.
    Coumans FA; Ligthart ST; Uhr JW; Terstappen LW
    Clin Cancer Res; 2012 Oct; 18(20):5711-8. PubMed ID: 23014524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.